Search Within

Alexander Edward Drilon

  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Journal Article (53)
  2. Meeting Abstract (45)
  3. Review (5)
  4. Editorial (2)
  5. Research Letter (1)
Groups
  1. Department of Medicine (106)
  2. Sloan Kettering Institute Postdocs (106)
  3. Solid Tumor Oncology Division (106)
  4. Thoracic Oncology (106)
  5. GSK Faculty (86)
  6. Department of Pathology and Laboratory Medicine (85)

More Groups

People
  1. Marc Ladanyi (59)
  2. Romel Somwar (38)
  3. Mark Kris (30)
  4. Gregory Riely (29)
  5. Maria Arcila (28)
  6. Charles Rudin (27)

More People

Years
  1. 2025 (2)
  2. 2024 (16)
  3. 2023 (10)
  4. 2022 (11)
  5. 2021 (9)
  6. 2020 (8)

More Years

Publications
  1. Journal of Clinical Oncology (18)
  2. Clinical Cancer Research (13)
  3. Journal of Thoracic Oncology (13)
  4. JCO Precision Oncology (8)
  5. Cancer Research (7)
  6. Cancer Discovery (6)

More Publications

Publishers
  1. American Association for Cancer Research (28)
  2. American Society of Clinical Oncology (27)
  3. Elsevier Inc. (18)
  4. Nature Publishing Group (12)
  5. Oxford University Press (7)
  6. Nature Research (2)

More Publishers

Results (106)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical outcomes with pemetrexed-based systemic therapy in RET-rearranged lung cancers
    Meeting Abstract

    Drilon, A.; Bergagnini, I.; Delasos, L.; Sima, C. S.; Smith, R.; Somwar, R.; Riely, G. J.; Kris, M. G.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Phase I trial of the HSP-90 inhibitor PU-H71
    Meeting Abstract

    Gerecitano, J. F.; Modi, S.; Rampal, R.; Drilon, A. E.; Fury, M. G.; Gounder, M. M.; Harding, J. J.; Hyman, D. M.; Varghese, A. M.; Voss, M. H.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase II study of cabozantinib for patients with advanced RET-rearranged lung cancers
    Meeting Abstract

    Drilon, A. E.; Sima, C. S.; Somwar, R.; Smith, R.; Ginsberg, M. S.; Riely, G. J.; Rudin, C. M.; Ladanyi, M.; Kris, M. G.; Rizvi, N. A.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • KIF5B-RET: Discovery of a novel fusion oncogene in lung adenocarcinomas by a systematic screen for tyrosine kinase fusions and identification of patients for a RET targeted therapy trial
    Meeting Abstract

    Suehara, Y.; Arcila, M. E.; Drilon, A. E. D.; Ito, T.; Wang, L.; Hasanovic, A.; Khanin, R.; Rizvi, N. A.; Ladanyi, M.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • The role of EGFR and KRAS mutations in locally advanced lung adenocarcinoma treated with definitive radiation therapy
    Meeting Abstract

    Rimner, A.; Wang, H.; Tsang, M.; Drilon, A.; Paik, P. K.; Hsu, M.; Zhang, Z.; Rosenzweig, K.; Wu, A. J.; Zakowski, M.
    Journal of Thoracic Oncology (2012)

    Fulltext@MSK | Save
  • Identification of KIF5B-RET and GOPC-ROS1 fusions in lung adenocarcinomas through a comprehensive mRNA-based screen for tyrosine kinase fusions
    Journal Article

    Suehara, Y.; Arcila, M.; Wang, L.; Hasanovic, A.; Ang, D.; Ito, T.; Kimura, Y.; Drilon, A.; Guha, U.; Rusch, V.; more...
    Clinical Cancer Research (2012)

    Fulltext@MSK | Save